- Home
- MSC vs COGT Comparison
MSC vs COGT Comparison
Compare MSC & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- COGT
- Stock Information
- Founded
- MSC 2000
- COGT 2014
- Country
- MSC Hong Kong
- COGT United States
- Employees
- MSC N/A
- COGT N/A
- Industry
- MSC Hotels/Resorts
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- COGT Health Care
- Exchange
- MSC Nasdaq
- COGT Nasdaq
- Market Cap
- MSC 924.4M
- COGT 1.1B
- IPO Year
- MSC 2018
- COGT 2018
- Fundamental
- Price
- MSC $4.61
- COGT $11.89
- Analyst Decision
- MSC
- COGT Strong Buy
- Analyst Count
- MSC 0
- COGT 9
- Target Price
- MSC N/A
- COGT $20.25
- AVG Volume (30 Days)
- MSC 3.1K
- COGT 1.7M
- Earning Date
- MSC 07-31-2025
- COGT 08-05-2025
- Dividend Yield
- MSC N/A
- COGT N/A
- EPS Growth
- MSC N/A
- COGT N/A
- EPS
- MSC N/A
- COGT N/A
- Revenue
- MSC $679,264,000.00
- COGT N/A
- Revenue This Year
- MSC $8.92
- COGT N/A
- Revenue Next Year
- MSC N/A
- COGT N/A
- P/E Ratio
- MSC N/A
- COGT N/A
- Revenue Growth
- MSC 15.03
- COGT N/A
- 52 Week Low
- MSC $2.30
- COGT $3.72
- 52 Week High
- MSC $9.30
- COGT $12.97
- Technical
- Relative Strength Index (RSI)
- MSC 51.26
- COGT 61.75
- Support Level
- MSC $4.48
- COGT $11.41
- Resistance Level
- MSC $5.04
- COGT $12.21
- Average True Range (ATR)
- MSC 0.40
- COGT 0.55
- MACD
- MSC -0.06
- COGT -0.13
- Stochastic Oscillator
- MSC 39.92
- COGT 79.47
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.